Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07135310) titled 'STROKE 120 ACTION: a National Cluster Randomized Controlled Trial' on Aug. 14.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Single (Outcomes Assessor).
Primary Sponsor: Shanghai Minhang Central Hospital
Condition:
Ischemic Stroke
Intervention:
Behavioral: STROKE 120 multifaceted intervention campaign
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: November 1, 2025
Target Sample Size: 1696000
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/ct2/show/NC...